NCT00005080 - 506U78 in Treating Patients With Lymphoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

January 31, 2006

Conditions

Anaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaRecurrent Adult T-cell Leukemia/LymphomaRecurrent Cutaneous T-cell Non-Hodgkin LymphomaRecurrent Mycosis Fungoides/Sezary SyndromeSmall Intestine LymphomaStage I Cutaneous T-cell Non-Hodgkin LymphomaStage I Mycosis Fungoides/Sezary SyndromeStage II Cutaneous T-cell Non-Hodgkin LymphomaStage II Mycosis Fungoides/Sezary SyndromeStage III Cutaneous T-cell Non-Hodgkin LymphomaStage III Mycosis Fungoides/Sezary SyndromeStage IV Cutaneous T-cell Non-Hodgkin LymphomaStage IV Mycosis Fungoides/Sezary Syndrome

Interventions

DRUG

nelarabine

Given IV

Trial Locations (1)

60606

Cancer and Leukemia Group B, Chicago

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH